Harbor Asset Planning’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.5K Hold
850
0.02% 305
2026
Q1
$23.9K Sell
850
-327
-28% -$8.71K 0.02% 283
2025
Q4
$29.3K Hold
1,177
0.03% 259
2025
Q3
$30K Hold
1,177
0.03% 245
2025
Q2
$28.5K Buy
+1,177
New +$27.4K 0.03% 240

Other funds holding PFE

Harbor Asset Planning's PFE Position: Q2 2026 in Review

Harbor Asset Planning held its Pfizer (PFE) position steady in Q2 2026 at 850 shares worth $20.5K. The position accounts for 0.02% of the portfolio, ranked #305.

Harbor Asset Planning first reported a position in PFE in Q2 2025 and has held it in 5 quarters since. The position peaked at $30K in Q3 2025. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Harbor Asset Planning held 850 shares of Pfizer worth $20.5K as of Q2 2026.
  • Harbor Asset Planning left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.02% of Harbor Asset Planning's portfolio in Q2 2026, its #305 holding.
  • Harbor Asset Planning first reported a position in Pfizer in Q2 2025 and has held it in 5 quarters since.
  • Harbor Asset Planning's Pfizer position peaked at $30K in Q3 2025.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Harbor Asset Planning's 13F filing for Q2 2026, filed 22 Jul 2026.